Toxoplasmosis-Associated Hemophagocytic Lymphohistiocytosis in Allogeneic Transplantation
- PMID: 33515363
- DOI: 10.1007/s10875-021-00979-8
Toxoplasmosis-Associated Hemophagocytic Lymphohistiocytosis in Allogeneic Transplantation
References
-
- Sandler RD, Tattersall RS, Schoemans H, et al. Diagnosis and Management of Secondary HLH/MAS following HSCT and CAR-T cell therapy in adults; a review of the literature and a survey of practice within EBMT Centres on behalf of the autoimmune diseases working party (ADWP) and transplant complications W. Front Immunol. 2020;11(March):1–10.
-
- Chen LYC, Hayden A, Mattman A. Extreme hyperferritinaemia, soluble interleukin-2 receptor, and haemophagocytic lymphohistiocytosis. Br J Haematol. 2019;185(3):605–6. - DOI
-
- Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, et al. Development and validation of the hscore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66(9):2613–20. - DOI
-
- Ho C, Yao X, Tian L, Li FY, Podoltsev N, Xu ML. Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability. Am J Clin Pathol. 2014;141(1):62–71. - DOI
-
- Duband S, Cornillon J, Tavernier E, Dumollard JM, Guyotat D, Péoc’h M. Toxoplasmosis with hemophagocytic syndrome after bone marrow transplantation: diagnosis at autopsy. Transpl Infect Dis. 2008;10(5):372–4. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical